Recombinant CD40L (Ruplizumab Biosimilar) anticorps
Aperçu rapide pour Recombinant CD40L (Ruplizumab Biosimilar) anticorps (ABIN7542960)
Antigène
Type d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Fonction
- Anti-CD40L [hu5c8 (Ruplizumab)], Mouse IgG2a, kappa
-
Specificité
-
The antibody binds to CD40L with an IC50 of 0.845 μg/mL.
Application Notes original Clone: The antibody binds specifically to CD40L, a surface receptor expressed on activated T cells which acts as a costimulatory molecule to trigger immune responses. The antibody neutralises CD40L function, as it blocks the interaction between CD40 and CD40L. When injected into cynomolgus monkeys, the original therapeutic antibody was found to have a T1/2 of 531 ±155 hours.
-
Attributs du produit
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.
-
Purification
- Protein A affinity purified
-
Immunogène
- Human CD40L
-
Isotype
- IgG2a, kappa
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
OriginalSpeciesName: Human
OriginalFormat: IgG1
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % Proclin 300.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
-
- CD40L (Ruplizumab Biosimilar) (CD40LG (Ruplizumab Biosimilar))
-
Autre désignation
- CD40L (Ruplizumab Biosimilar)
-
Classe de substances
- Biosimilar
-
Sujet
- CD154, CD40 ligand, tumour necrosis factor ligand superfamily member 5, TNFSF5, tumour necrosis factor related activation protein, TRAP
-
UniProt
- P29965
Antigène
-